BIO-B
BIO-RAD LABORATORIES, INC.$364.15 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $364.15
Market cap
$9.7B
Mid cap
1 year
+13.4%
from $321.12 · Oct 27
30 days
−0.3%
from $365.08
52-week range
$255.54–365.08
−0% from high · low May 8
Avg volume 20D
10
Oct 14 spike 200
Short interest
1
Days to cover
1.0
at average volume
New fund stakes
0
Q1 2026 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Jun 15 Short interest falls 98.9% to 1
- X Jun 30 Short interest jumps 21900.0% to 220
- X Jul 15 Short interest falls 85.9% to 31
- X Jul 31 Short interest falls 93.5% to 2
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q1 2026: 1 added (0 new), 0 trimmed or exited.
- TrendRANGE
0% above its 50-day average.
Who's buying
13F· Q1 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| UBS Group AG | ADD | $3.6K |
| UBS Group AG | DOUBLED | $716.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Sep 30, 20261
shares short
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Apr 24, 2026 SEC
Bio-Rad Laboratories amended its 2017 Incentive Award Plan, increasing the share reserve by 335,000 shares and…
8-K — Impact 4/10
Mar 31, 2026 Inst.
UBS Group AG — ADD
13 shares ($3.6K)
Jun 30, 2025 Inst.
UBS Group AG — DOUBLED
3 shares ($716.00)
SecBot reports
1 filing · 0 bullish · 0 bearish · 1 neutralAll BIO-B filing & press-release reports (1)
- 8-K reportApr 24, 2026